Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Yong Suk Jo, Ju-Hee Park, Jung Kyu Lee, Eun Young Heo, Hee Soon Chung & Deog Kyeom Kim. (2017) Risk factors for pulmonary arterial hypertension in patients with tuberculosis-destroyed lungs and their clinical characteristics compared with patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2433-2443.
Read now
Read now
Jan Grimminger, Hossein Ardeschir Ghofrani, Nobert Weissmann, Hans Klose & Friedrich Grimminger. (2016) COPD-associated pulmonary hypertension: clinical implications and current methods for treatment. Expert Review of Respiratory Medicine 10:7, pages 755-766.
Read now
Read now
J Michael Wells & Mark T Dransfield. (2013) Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 509-521.
Read now
Read now
J. L. Wright, S. Zhou & A. Churg. (2012) Pulmonary hypertension and vascular oxidative damage in cigarette smoke exposed eNOS−/− mice and human smokers. Inhalation Toxicology 24:11, pages 732-740.
Read now
Read now
Brian D Kent, Patrick D Mitchell & Walter T McNicholas. (2011) Hypoxemia in patients with COPD: cause, effects, and disease progression. International Journal of Chronic Obstructive Pulmonary Disease 6, pages 199-208.
Read now
Read now
Joanne L Wright & Andrew Churg. (2010) Animal models of cigarette smoke-induced chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine 4:6, pages 723-734.
Read now
Read now
Articles from other publishers (36)
Jennifer M. Wang, Wassim W. Labaki, Susan Murray, Fernando J. Martinez, Jeffrey L. Curtis, Eric A. Hoffman, Sundaresh Ram, Alexander J. Bell, Craig J. Galban, MeiLan K. Han & Charles Hatt. (2023) Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV1 decline: results from COPDGene and SPIROMICS. Frontiers in Physiology 14.
Crossref
Crossref
Sergey I. Dikalov, Sergey Gutor & Anna E. Dikalova. (2023) Pathological mechanisms of cigarette smoking, dietary, and sedentary lifestyle risks in vascular dysfunction: mitochondria as a common target of risk factors. Pflügers Archiv - European Journal of Physiology.
Crossref
Crossref
Prem Bhattarai, Wenying Lu, Archana Vijay Gaikwad, Surajit Dey, Collin Chia, Josie Larby, Greg Haug, Ashutosh Hardikar, Andrew Williams, Gurpreet Kaur Singhera, Tillie-Louise Hackett, Mathew Suji Eapen & Sukhwinder Singh Sohal. (2022) Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension. ERJ Open Research 8:4, pages 00254-2022.
Crossref
Crossref
Benjamin Grimmer, Adrienn Krauszman, Xudong Hu, Golam Kabir, Kim A Connelly, Mei Li, Jana Grune, Christian Madry, Brant E Isakson & Wolfgang M Kuebler. (2022) Pannexin 1: a novel regulator of acute hypoxic pulmonary vasoconstriction. Cardiovascular Research 118:11, pages 2535-2547.
Crossref
Crossref
Lillian Truong, Yun-Min Zheng & Yong-Xiao Wang. (2022) The Potential Important Role of Mitochondrial Rieske Iron–Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease. Biomedicines 10:5, pages 957.
Crossref
Crossref
Hüsnü BAYKAL & Emel BULCUN. (2022) Relationship of Clinical Parameters and Inflammation Markers with Pulmonary Hypertension in Patients with Stable Chronic Obstructive Pulmonary DiseaseStabil Kronik Obstrüktif Akciğer Hastalığı Olan Hastalarda Klinik Parametreler ve İnflamasyon Belirteçlerinin Pulmoner Hipertansiyon ile İlişkisi. Sağlık Bilimlerinde Değer 12:1, pages 6-14.
Crossref
Crossref
Takaaki Suzuki, Kimihiko Hirose, Fumiko Tabei, Yasuyuki Sugishita, Teruaki Oka, Satoshi Ishii, Takayuki Fujiwara, Norifumi Takeda, Issei Komuro & Nobuhiko Itoh. (2021) An Autopsy Case of Pulmonary Veno-Occlusive Disease Complicated with Chronic Obstructive Pulmonary Disease and Severe Pulmonary Hypertension. International Heart Journal 62:5, pages 1186-1190.
Crossref
Crossref
Ankit Kumar Sahu & Sudeep Kumar. (2021) Pulmonary Hypertension - A Distinct Perspective. Journal of Evidence Based Medicine and Healthcare 8:26, pages 2349-2362.
Crossref
Crossref
Minkwan Kim, Hyun‐Jung Lee, Jun‐Bean Park, Jihoon Kim, Seung‐Pyo Lee, Yong‐Jin Kim, Sung‐A Chang & Hyung‐Kwan Kim. (2021) Preoperative Right Ventricular Free‐Wall Longitudinal Strain as a Prognosticator in Isolated Surgery for Severe Functional Tricuspid Regurgitation. Journal of the American Heart Association 10:9.
Crossref
Crossref
Srikanth Karnati, Michael Seimetz, Florian Kleefeldt, Avinash Sonawane, Thati Madhusudhan, Akash Bachhuka, Djuro Kosanovic, Norbert Weissmann, Karsten Krüger & Süleyman Ergün. (2021) Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Eskandarain Shafuddin, Sarah M. Fairweather, Catherina L. Chang, Christine Tuffery & Robert J. Hancox. (2021) Cardiac biomarkers and long-term outcomes of exacerbations of COPD: a long-term follow-up of two cohorts. ERJ Open Research 7:1, pages 00531-2020.
Crossref
Crossref
Athanasios Fysikopoulos, Michael Seimetz, Stefan Hadzic, Fenja Knoepp, Cheng‐Yu Wu, Kathrin Malkmus, Jochen Wilhelm, Alexandra Pichl, Mariola Bednorz, Elsa Tadele Roxlau, Hossein A. Ghofrani, Natascha Sommer, Mareike Gierhardt, Ralph T. Schermuly, Werner Seeger, Friedrich Grimminger, Norbert Weissmann & Simone Kraut. (2020) Amelioration of elastase‐induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice. British Journal of Pharmacology 178:1, pages 152-171.
Crossref
Crossref
Todd Tartavoulle, Laura S. Bonanno & Stanley Hall. (2019) Perioperative Considerations for Patients Diagnosed With Pulmonary Hypertension Undergoing Noncardiac Surgery. Journal of PeriAnesthesia Nursing 34:2, pages 240-249.
Crossref
Crossref
Mohammad K. Mojadidi, Juan C. Ruiz, Jason Chertoff, Muhammad O. Zaman, Islam Y. Elgendy, Ahmed N. Mahmoud, Mohammad Al-Ani, Akram Y. Elgendy, Nimesh K. Patel, Ghanshyam Shantha, Jonathan M. Tobis & Bernhard Meier. (2019) Patent Foramen Ovale and Hypoxemia. Cardiology in Review 27:1, pages 34-40.
Crossref
Crossref
Vanessa Neumann, Ralf Knies, Alexander Seidinger, Annika Simon, Kristina Lorenz, Michaela Matthey, Johannes Breuer & Daniela Wenzel. (2018)
The β
2
agonist terbutaline specifically decreases pulmonary arterial pressure under normoxia and hypoxia via a adrenoceptor antagonism
. The FASEB Journal 32:5, pages 2519-2530.
Crossref
Crossref
Asha Rangadham & Varun Dasegowdanapalya Gangaiah. (2018) USE OF ECG AND OTHER CLINICAL VARIABLES FOR DETECTING PULMONARY HYPERTENSION IN COPD PATIENTS- A CROSS-SECTIONAL OBSERVATIONAL STUDY. Journal of Evolution of Medical and Dental Sciences 7:02, pages 167-170.
Crossref
Crossref
Talari Swathi, Dasari Nishanth Vudela, Deepika Kucherlapati & Goutam B. (2018) THE STUDY OF ELECTROCARDIOGRAPHIC AND ECHOCARDIOGRAPHIC CHANGES IN COPD. Journal of Evolution of Medical and Dental Sciences 7:02, pages 135-141.
Crossref
Crossref
Umul Fadlilah, Didik Hasmono, Yudi Agung Wibisono & Mia Melinda. (2017) ANTIBIOGRAM STUDY AND ANTIBIOTIC USE EVALUATION USING GYSSEN METHOD IN PATIENTS WITH DIABETIC FOOT. Folia Medica Indonesiana 52:3, pages 198.
Crossref
Crossref
Sreenivasan Sreenath, Santhosh Kumar Thulaseedharan Saraswathy & Rajeevan Sreekumaran Nair. (2017) LV DYSFUNCTION IN COPD PATIENTS AND ITS CORRELATION WITH CLINICAL AND ECG FINDINGS. Journal of Evidence Based Medicine and Healthcare 4:55, pages 3336-3342.
Crossref
Crossref
Basavaraj Mangshetty G & Kunireddy Apuroopa. (2016) STUDY OF CLINICAL PROFILE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND EVALUATION OF PULMONARY HYPERTENSION WITH ECG AND 2D ECHO FINDINGS. Journal of Evolution of Medical and Dental Sciences 5:100, pages 7331-7336.
Crossref
Crossref
Julia Hoffmann, Jochen Wilhelm, Andrea Olschewski & Grazyna Kwapiszewska. (2016) Microarray analysis in pulmonary hypertension. European Respiratory Journal 48:1, pages 229-241.
Crossref
Crossref
Virendra Pratap Singh Rathor, Pradeep Chugh, Rashid Ali, Anuj Bhatnagar, Syed Ehtaishamul Haque, Aseem Bhatnagar & Gaurav Mittal. (2016) Formulation, preclinical and clinical evaluation of a new submicronic arginine respiratory fluid for treatment of chronic obstructive pulmonary disorder. Saudi Pharmaceutical Journal 24:1, pages 49-56.
Crossref
Crossref
Jeremy P. Wrobel, Bruce R. Thompson, Christopher R. Stuart-Andrews, Kirk Kee, Gregory I. Snell, Mark Buckland & Trevor J. Williams. (2015) Intermittent positive pressure ventilation increases diastolic pulmonary arterial pressure in advanced COPD. Heart & Lung 44:1, pages 50-56.
Crossref
Crossref
Monica Rocco, Elisa Alessandri, Amalia Laderchi, Silvia Marsili & Giorgio Conti. (2013) Respiratory failure in COPD. Trends in Anaesthesia and Critical Care 3:3, pages 105-108.
Crossref
Crossref
Wim Timens, Hannie Sietsma & Joanne L. Wright. 2014. Spencer's Pathology of the Lung. Spencer's Pathology of the Lung
605
660
.
Jinkyeong ParkJu Hee SongDong-Ah ParkJae Seoung LeeSang-Do LeeYeon-Mok Oh. (2013) Systematic Review and Meta-Analysis of Pulmonary Hypertension Specific Therapy for Exercise Capacity in Chronic Obstructive Pulmonary Disease. Journal of Korean Medical Science 28:8, pages 1200.
Crossref
Crossref
John J. Ryan, Glenn Marsboom & Stephen L. Archer. 2013. Pharmacotherapy of Pulmonary Hypertension. Pharmacotherapy of Pulmonary Hypertension
105
149
.
John J. Ryan, Thenappan Thenappan, Nancy Luo, Thanh Ha, Amit R. Patel, Stuart Rich & Stephen L. Archer. (2012) The WHO Classification of Pulmonary Hypertension: A Case‐Based Imaging Compendium. Pulmonary Circulation 2:1, pages 107-121.
Crossref
Crossref
Claudio Micheletto. 2012. Long-Term Oxygen Therapy. Long-Term Oxygen Therapy
195
210
.
Jin Won HuhSun-Yong KimJi Hyun LeeJin-Seok LeeQuang Van TaMiJung Kim, Yeon-Mok Oh, Yun-Song LeeSang-Do Lee. (2011) Bone marrow cells repair cigarette smoke-induced emphysema in rats. American Journal of Physiology-Lung Cellular and Molecular Physiology 301:3, pages L255-L266.
Crossref
Crossref
Mardi Gomberg-Maitland, Thenappan Thenappan, John J. Ryan, Ankush Goel, Nicole Cipriani, Aliya N. Husain, Amit Patel, Savitri E. Fedson & Stephen L. Archer. 2011. Textbook of Pulmonary Vascular Disease. Textbook of Pulmonary Vascular Disease
1355
1376
.
Tomonobu KOIZUMI, Kazuhisa URUSHIHATA, Masayuki HANAOKA, Kenji TSUSHIMA, Keisaku FUJIMOTO, Tadashige FUJII & Keishi KUBO. (2010) Iodine-123 metaiodobenzylguanidine scintigraphic assessment of pulmonary vascular status in patients with chronic obstructive pulmonary disease. Respirology 15:8, pages 1215-1219.
Crossref
Crossref
Karin Schmid, Silvia Pascual, Esther Garcia Gil, Stephan Ortiz & Josep M. Jansat. (2010) Pharmacokinetics and safety of aclidinium bromide, a muscarinic antagonist, in adults with normal or impaired renal function: A phase I, open-label, single-dose clinical trial. Clinical Therapeutics 32:10, pages 1798-1812.
Crossref
Crossref
Alan F Ross & Kenichi Ueda. (2010) Pulmonary hypertension in thoracic surgical patients. Current Opinion in Anaesthesiology 23:1, pages 25-33.
Crossref
Crossref
ANTONELLO PUNTURIERI, GAIL G. WEINMANN & HERBERT Y. REYNOLDS. 2010. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
877
883
.
Anderson J. Ferreira, Vinayak Shenoy, Yoriko Yamazato, Srinivas Sriramula, Joseph Francis, Lihui Yuan, Ronald K. Castellano, David A. Ostrov, Suk Paul Oh, Michael J. Katovich & Mohan K. Raizada. (2009) Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine 179:11, pages 1048-1054.
Crossref
Crossref